Chennai Journal

The Acute Gout Flare Market to Grow Positively at a Significant CAGR During the Study Period (2019-2032), estimates DelveInsight

 Breaking News
  • No posts were found

The Acute Gout Flare Market to Grow Positively at a Significant CAGR During the Study Period (2019-2032), estimates DelveInsight

February 08
20:50 2023
The Acute Gout Flare Market to Grow Positively at a Significant CAGR During the Study Period (2019-2032), estimates DelveInsight

DelveInsight’sAcute Gout Flare Market Insight, Epidemiology and Market Forecast 2032 report provides current treatment practices, emerging drugs, Acute Gout Flare market share of the individual therapies, current and forecasted Acute Gout Flare market size from 2019 to 2032 segmented by seven major markets. The report also offers current Acute Gout Flare therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Gout Flare market.


Acute Gout Flare Overview

Gout is a common and complex form of arthritis that can affect anyone. It’s characterized by sudden, severe attacks of pain, swelling, redness and tenderness in one or more joints, most often in the big toe.

An attack of gout can occur suddenly, often waking you up in the middle of the night with the sensation that your big toe is on fire. The affected joint is hot, swollen and so tender that even the weight of the bedsheet on it may seem intolerable.

Gout symptoms may come and go, but there are ways to manage symptoms and prevent flares.


Acute Gout Flare Epidemiological Insights

Gout is a common cause of inflammatory arthritis. Among the United States adult population, the gout prevalence is 3.9%.


Acute Gout Flare Treatment Market 

Current guidelines from the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) advise that long-term urate-lowering therapy (ULT), with the aim of maintaining serum urate levels (generally below 6 mg/dL), is key to effective control of gout and should be initiated in the presence of certain clinical features: for example, tophi, frequent gouty attacks (flares; two or more per year), and urate arthropathy. 

Effective options for the treatment of the acute attack include non-steroidal anti-inflammatory drugs (NSAIDs), intra-articular corticosteroids and systemic corticosteroid therapy. With respect to efficacy (although not toxicity) the rapidity with which therapy is commenced appears to be more important than which medication is used. The best choice is often determined by whether or not there are contraindications to NSAID use, such as renal or cardiac insufficiency or a history of peptic ulceration. 

Provided synovial fluid has been sent for analysis, including culture, it is reasonable to administer intra-articular corticosteroid immediately following joint aspiration (without removing the needle from the joint) when gout appears likely, even though sepsis has not yet been excluded. Systemic corticosteroid therapy can be provided as oral prednisone 20–40 mg daily in divided doses reducing to zero in 10–14 days or intramuscular depot tetracosactrin 1 mg, a synthetic analog of ACTH. 


Promising Therapies in the Acute Gout Flare Pipeline

  • DYV700 
  • RPH – 104
  • Anakinra 
  • And others


Discover more about Acute Gout Flare therapies in the pipeline @ Acute Gout Flare Drugs


Leading Companies Working in the Acute Gout Flare Market

  • Dyve Biosciences, Inc. 
  • R-Pharm
  • Swedish Orphan Biovitrum
  • And others


To understand key companies related to the Acute Gout Flare Market, get a snapshot of the Acute Gout Flare Regulatory and Patent Analysis.


Scope of the Acute Gout Flare Market Report

Study Period: 2019–2032

Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]

Key Acute Gout Flare Companies: Dyve Biosciences, Inc., R-Pharm, Swedish Orphan Biovitrum, and others.

Key Acute Gout Flare Pipeline Therapies: DYV700, RPH – 104, Anakinra, and others

Therapeutic Assessment: Acute Gout Flare current marketed and emerging therapies

Acute Gout Flare Market Dynamics: Acute Gout Flare market drivers and barriers 

Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

Unmet Needs, KOL’s views, Analyst’s views, Acute Gout Flare Market Access and Reimbursement


Table of Contents

1. Acute Gout Flare Market Key Insights

2. Acute Gout Flare Market Report Introduction

3. Acute Gout Flare Market Overview at a Glance

4. Acute Gout Flare Market Executive Summary

5. Disease Background and Overview

6. Acute Gout Flare Treatment and Management

7. Acute Gout Flare Epidemiology and Patient Population

8. Patient Journey

9. Acute Gout Flare Emerging Drugs

10. 7MM Acute Gout Flare Market Analysis

11. Acute Gout Flare Market Outlook

12. Potential of Current and Emerging Therapies

13. KOL Views

14. Acute Gout Flare Market Drivers

15. Acute Gout Flare Market Barriers

16. Unmet Needs

17. SWOT Analysis

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight


Trending Report Offerings by DelveInsight:

  • Gender Dysphoria Market
  • Germany Healthcare Outlook Market
  • Hyperlipidemia Market
  • Mammography Devices Market
  • Dental Equipment Market
  • Adalimumab Biosimilar Market
  • Hyperlipidemia Market
  • Metastatic Cutaneous Squamous Cell Cancer Market
  • Mucopolysaccharidosis Market


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.


Contact Us

Kritika Rehani

[email protected] 


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States